Skip to content

EEG-based study of brain function in patients with mild cognitive impairment combined with nocturia

EEG-based study of brain function in patients with mild cognitive impairment combined with nocturia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079328
Enrollment
Unknown
Registered
2023-12-31
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild cognitive impairment combined with nocturia

Interventions

MCI-nocturia group:None
MCI-non-nocturia group:None

Sponsors

Shenzhen Baoan District People's Hospital(The Second Affiliated Hospital of Shenzhen University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for MCI-nocturia group: (1) Meeting the diagnostic criteria for both mild cognitive impairment and nocturia; (2) Age 60 years or older; (3) Montreal Cognitive Assessment Scale score = 26; (4) Pittsburgh Sleepiness Scale score = 5; (5) Signed informed consent and voluntary participation. Inclusion criteria for the MCI-non-nocturia group (1) Age 60 years or older; (2) Montreal Cognitive Assessment Scale score = 26; (3) Nocturnal urination = 1 time; (4) Pittsburgh Sleepiness Scale score = 5; (5) Signed informed consent and voluntary participation.

Exclusion criteria

Exclusion criteria: MCI combined with nocturia group exclusion criteria. (1) Sleep apnea; (2) Severe urinary incontinence (e.g., need for nocturnal protective clothing), indwelling urinary catheters, uremia, and those with urinary tract infections; (3) Poorly controlled type 1 or type 2 diabetes mellitus (e.g., condition is untreated or has required a change or adjustment in medication within the past 30 days); (4) Urinary tract infection in the past 2 weeks; (5) Self-reported irritable thirst (excessive fluid intake, more than 3 cups [24L]/2 hours) or feeling extremely thirsty and drinking large amounts of fluids not related to exercise within the past 12 weeks; (6) Those with a history of stroke such as cerebral infarction cerebral hemorrhage, subarachnoid hemorrhage, etc., within the past year or with a combination of serious systemic diseases such as cardiovascular, cerebrovascular, hematopoietic, or other systemic diseases; (7) Previous history of prostate, urethra or bladder surgery, bladder or prostate tumor; (8) Anxiety and depression; (9) Those with communication disorders such as intellectual disability or unfavorable speech. Exclusion criteria for the control group (1) Severe psychosomatic systemic diseases, anxiety disorder, depression, etc; (2) Diabetes mellitus or acute metabolic complications of diabetes mellitus or history of severe diabetic ketoacidosis, hypoglycemic coma; (3) Comorbid serious primary diseases, such as cardiovascular, cerebrovascular, hepatic, renal and hematologic disorders; (4) Taking drugs that affect cognition (antipsychotics, benzodiazepines, etc.); (5) Epilepsy or a family history of epilepsy, hypothyroidism or some other factor that may affect cognitive function; (6) Those who are unable to complete the assessment of indicators, such as severe aphasia, audiovisual impairment, etc.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment Scale (Moca);Nocturia Quality of Life Questionnaire (N-QOL) scores;24-hour urination diary;electroencephalogram index;

Secondary

MeasureTime frame
Hamilton Depression Rating Scale (HAMD);Hamilton Depression Rating Scale;Pittsburgh Sleep Quality Index ;

Countries

China

Contacts

Public ContactXingchen Zhou; Shangjie Chen

Shenzhen Baoan District People's Hospital(The Second Affiliated Hospital of Shenzhen University)

csjme@163.com+86 158 9979 7851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026